We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin
Industry Insight

Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin

A new study has compared the effects of varied doses of psilocybin and LSD for the first time. These two popular psychedelics have been of increasing interest in clinical research. Technology Networks caught up with Rob Barrow, CEO of MindMed, to discuss the findings in more detail and explore pressing issues around blinding in psychedelic drug development.


Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future
Industry Insight

Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future

Dr. Christian Landles explains why it is so challenging to develop therapeutics for rare diseases such as HD, and discusses the potential of approaches that target mutant huntingtin protein to improve treatment options for HD patients.
Driving Forward Huntington’s Disease Research
Industry Insight

Driving Forward Huntington’s Disease Research

Dr. Christian Landles highlights some of the progress made in recent years to improve our understanding of HD and its drivers.
Exploring How VR Could Be Used in Psychedelic-Assisted Psychotherapy
Industry Insight

Exploring How VR Could Be Used in Psychedelic-Assisted Psychotherapy

Psychedelic-assisted psychotherapy (PAP) is under investigation for its potential in treating psychiatric conditions. A recent paper, published by academics Agnieszka Sekula and Dr. Prash Puspanathan, outlined how virtual reality (VR) might be incorporated into aspects of the PAP process.
Live Biotherapeutics ‒ A Novel Way To Treat Disease
Industry Insight

Live Biotherapeutics ‒ A Novel Way To Treat Disease

The intricate and intertwined nature of the host‒microbiota connection has garnered increasing interest from the scientific community in recent years, due to its known role in the development and progression of various diseases. 4D pharma has leveraged growing knowledge in the field, by creating a novel class of medicines called live biotherapeutic products (LBPs).
Harnessing the Potential of Bioelectronic Medicine To Treat Essential Tremors
Industry Insight

Harnessing the Potential of Bioelectronic Medicine To Treat Essential Tremors

Technology Networks spoke to Renee Ryan, Cala Health's CEO, to learn more about bioelectronic medicine and its use as a therapy for essential tremors.
How Restoring Brain Plasticity Is the Secret to Reversing Brain Damage
Industry Insight

How Restoring Brain Plasticity Is the Secret to Reversing Brain Damage

For the world’s leading neuroscientists, unlocking the brain’s capacity to stimulate neural plasticity has become something of a Holy Grail. In this Insight, NervGen Pharma president and CEO Paul Brennan details why plasticity is so important for the brain.


Using Bioelectronic Assays To Advance Drug Discovery for Neurological Diseases
Industry Insight

Using Bioelectronic Assays To Advance Drug Discovery for Neurological Diseases

In this interview, Jim Ross highlights several recent examples of how bioelectronic assays are helping to advance drug discovery for neurological diseases ranging from pediatric epilepsy to Burning Man Syndrome.
When We Become Leaders, How Do We Lead Science Towards Gender Equity?
Industry Insight

When We Become Leaders, How Do We Lead Science Towards Gender Equity?

Emulate's chief scientific officer, Dr. Lorna Ewart, talks about inspiring a new generation of women in STEM.
CRACKing the Brain’s Cellular Code: An Interview With Professor Jerry Chen
Industry Insight

CRACKing the Brain’s Cellular Code: An Interview With Professor Jerry Chen

Unpicking our brain's complexity at a cellular level is a mammoth task. How do our genes, cells and electrical impulses come together to decode the world around us? At Boston University Assistant Professor Jerry Chen is trying to crack this code. In this interview, we speak to Chen about his study’s aims, findings and implications.
Advertisement